Saratoga Investment Corp 750 Notes due 2031 SAV Q1 2026 Earnings Substantial EPS Miss Weighs on Investor Sentiment Quince Therapeutics Inc QNCX Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Over 200 OIS Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Mixed Market Conditions KW Q1 2026 Earnings EPS Surprise of 1647 Highlights Cost Discipline Amidst Flat Revenue STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges GSL Q1 2026 Earnings EPS Surpasses Estimates by 314 Amid Market Volatility